Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, Vignat J, Ferlay J, Murphy N, Bray F. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72:338–44. https://doi.org/10.1136/gutjnl-2022-327736.
Long D, Mao C, Zhang Z, Liu Y, Li J, Xu Y, Zhu Y. Long-term trends in the burden of colorectal cancer in Europe over three decades: a joinpoint regression and age-period-cohort analysis. Front Oncol. 2023;13:1287653. https://doi.org/10.3389/fonc.2023.1287653.
Article PubMed PubMed Central Google Scholar
Li N, Lu B, Luo C, Cai J, Lu M, Zhang Y, Chen H, Dai M. Incidence, mortality, survival, risk factor and screening of colorectal cancer: a comparison among China, Europe, and northern America. Cancer Lett. 2021;522:255–68. https://doi.org/10.1016/j.canlet.2021.09.034.
Article CAS PubMed Google Scholar
Hu S, Li Y, Zhu W, Liu J, Wei S. Global, region and national trends and age-period-cohort effects in colorectal cancer burden from 1990 to 2019, with predictions to 2039. Environ Sci Pollut Res Int. 2023;30:83245–59. https://doi.org/10.1007/s11356-023-28223-3.
Chauca Strand G, Stromberg U, Forsberg A, Bonander C. Impact of organised colorectal cancer screening on age-specific population incidences: evidence from a quasi-experimental study in Sweden. Eur J Epidemiol. 2024;39:87–96. https://doi.org/10.1007/s10654-023-01073-6.
Article PubMed PubMed Central Google Scholar
Maugeri A, Barchitta M, Magnano San Lio R, Li Destri G, Agodi A, Basile G. Epigenetic aging and colorectal cancer: state of the art and perspectives for future research. Int J Mol Sci. 2020;22(1):200. https://doi.org/10.3390/ijms22010200.
Article CAS PubMed PubMed Central Google Scholar
Joshi AD, Chan AT. Racial differences in epigenetic aging of the colon: implications for colorectal cancer. J Natl Cancer Inst. 2021;113:1618–9. https://doi.org/10.1093/jnci/djaa207.
Fekete M, Major D, Feher A, Fazekas-Pongor V, Lehoczki A. Geroscience and pathology: a new frontier in understanding age-related diseases. Pathol Oncol Res. 2024;30:1611623. https://doi.org/10.3389/pore.2024.1611623.
Saul D, Kosinsky RL, Atkinson EJ, Doolittle ML, Zhang X, LeBrasseur NK, Pignolo RJ, Robbins PD, Niedernhofer LJ, Ikeno Y, et al. A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nat Commun. 2022;13:4827. https://doi.org/10.1038/s41467-022-32552-1.
Article CAS PubMed PubMed Central Google Scholar
Chaib S, Tchkonia T, Kirkland JL. Cellular senescence and senolytics: the path to the clinic. Nat Med. 2022;28:1556–68. https://doi.org/10.1038/s41591-022-01923-y.
Article CAS PubMed PubMed Central Google Scholar
Tuttle CSL, Waaijer MEC, Slee-Valentijn MS, Stijnen T, Westendorp R, Maier AB. Cellular senescence and chronological age in various human tissues: a systematic review and meta-analysis. Aging Cell. 2020;19:e13083. https://doi.org/10.1111/acel.13083.
Article CAS PubMed Google Scholar
Childs BG, Durik M, Baker DJ, van Deursen JM. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med. 2015;21:1424–35. https://doi.org/10.1038/nm.4000.
Article CAS PubMed PubMed Central Google Scholar
Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol. 2013;75:685–705. https://doi.org/10.1146/annurev-physiol-030212-183653.
Article CAS PubMed Google Scholar
Lecot P, Alimirah F, Desprez PY, Campisi J, Wiley C. Context-dependent effects of cellular senescence in cancer development. Br J Cancer. 2016;114:1180–4. https://doi.org/10.1038/bjc.2016.115.bjc2016115[pii].
Article CAS PubMed PubMed Central Google Scholar
Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest. 2013;123:966–72. https://doi.org/10.1172/JCI64098.64098[pii].
Article CAS PubMed PubMed Central Google Scholar
Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99–118. https://doi.org/10.1146/annurev-pathol-121808-102144.
Article CAS PubMed PubMed Central Google Scholar
Yu S, Chen M, Xu L, Mao E, Sun S. A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence. Front Immunol. 2023;14:1175490. https://doi.org/10.3389/fimmu.2023.1175490.
Article CAS PubMed PubMed Central Google Scholar
Levi N, Papismadov N, Solomonov I, Sagi I, Krizhanovsky V. The ECM path of senescence in aging: components and modifiers. FEBS J. 2020;287:2636–46. https://doi.org/10.1111/febs.15282.
Article CAS PubMed Google Scholar
Gyorffy B, Surowiak P, Budczies J, Lanczky A. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS ONE. 2013;8:e82241. https://doi.org/10.1371/journal.pone.0082241.
Article CAS PubMed PubMed Central Google Scholar
Gyorffy B. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Br J Pharmacol. 2024;181:362–74. https://doi.org/10.1111/bph.16257.
Article CAS PubMed Google Scholar
Huang E, Ma T, Zhou J, Ma N, Yang W, Liu C, Hou Z, Chen S, Zong Z, Zeng B, et al. A novel senescence-associated LncRNA signature predicts the prognosis and tumor microenvironment of patients with colorectal cancer: a bioinformatics analysis. J Gastrointest Oncol. 2022;13:1842–63. https://doi.org/10.21037/jgo-22-721.
Article PubMed PubMed Central Google Scholar
Lv MY, Cai D, Li CH, Chen J, Li G, Hu C, Gai B, Lei J, Lan P, Wu X, et al. Senescence-based colorectal cancer subtyping reveals distinct molecular characteristics and therapeutic strategies. MedComm. 2020;2023(4):e333. https://doi.org/10.1002/mco2.333.
Zhang X, Huang Y, Li Q, Zhong Y, Zhang Y, Hu J, Liu R, Luo X. Senescence risk score: a multifaceted prognostic tool predicting outcomes, stemness, and immune responses in colorectal cancer. Front Immunol. 2023;14:1265911. https://doi.org/10.3389/fimmu.2023.1265911.
Article CAS PubMed PubMed Central Google Scholar
Melia F, Udomjarumanee P, Zinovkin D, Arghiani N, Pranjol MZI. Pro-tumorigenic role of type 2 diabetes-induced cellular senescence in colorectal cancer. Front Oncol. 2022;12:975644. https://doi.org/10.3389/fonc.2022.975644.
Article CAS PubMed PubMed Central Google Scholar
Kehagias P, Kindt N, Krayem M, Najem A, Agostini G, Acedo Reina E, Bregni G, Sclafani F, Journe F, Awada A, et al. Regorafenib induces senescence and epithelial-mesenchymal transition in colorectal cancer to promote drug resistance. Cells. 2022;11(22):3663. https://doi.org/10.3390/cells11223663.
Article CAS PubMed PubMed Central Google Scholar
Choi YW, Kim YH, Oh SY, Suh KW, Kim YS, Lee GY, Yoon JE, Park SS, Lee YK, Park YJ, et al. Senescent tumor cells build a cytokine shield in colorectal cancer. Adv Sci (Weinh). 2021;8:2002497. https://doi.org/10.1002/advs.202002497.
Article CAS PubMed Google Scholar
Li Y, Xu X, Wang L, Liu G, Li Y, Wu X, Jing Y, Li H, Wang G. Senescent mesenchymal stem cells promote colorectal cancer cells growth via galectin-3 expression. Cell Biosci. 2015;5:21.
留言 (0)